Internal Medicine, Medical Oncology · Duarte, CA
NPI
1700938180
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 359-8111
Groups this clinician bills Medicare through
Medicare paid, 2024
$90K
1,116 services
Medicare patients, 2024
252
Average age 74
Drug cost, 2024
$5.7M
582 prescriptions
Company payments, 2025
$1,010
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sumanta K Pal was code 99214 (office e&m - established), 590 times for 180 patients. In total Sumanta K Pal billed 1,116 services in 12 codes, and Medicare paid $90K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 590 | 180 | $81.00 | $48K |
| 99215 Office E&M - Established | Facility | 142 | 82 | $122.20 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 139 | 91 | $14.23 | $1,978 |
| 99214 Office E&M - Established | Office | 91 | 48 | $100.67 | $9,161 |
| 99213 Office E&M - Established | Facility | 56 | 45 | $45.85 | $2,568 |
| 99205 Office E&M - New | Office | 40 | 40 | $166.07 | $6,643 |
| 99215 Office E&M - Established | Office | 20 | 18 | $124.53 | $2,491 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $14.23 | $199 |
By year: 2022 $140K for 2,480 services; 2023 $76K for 978 services; 2024 $90K for 1,116 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sumanta K Pal prescribed most often to Medicare patients was Cabometyx (Cabozantinib S-Malate), with 130 prescriptions and refills. In total Sumanta K Pal wrote 582 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cabometyx Cabozantinib S-Malate | 130 | 130 | 22 | $3.3M |
| Orgovyx Relugolix | 42 | 42 | Under 11 | $107K |
| Fotivda Tivozanib Hcl | 37 | 37 | Under 11 | $1.1M |
| Pantoprazole Sodium Generic | 31 | 39 | Under 11 | $213 |
| Prednisone Generic | 27 | 45 | 13 | $193 |
| Welireg Belzutifan | 21 | 21 | Under 11 | $527K |
| Ondansetron Odt Ondansetron | 21 | 21 | Under 11 | $207 |
| Levothyroxine Sodium Generic | 21 | 45 | Under 11 | $142 |
| Everolimus Generic | 20 | 20 | Under 11 | $100K |
| Eliquis Apixaban | 18 | 23 | Under 11 | $12K |
| Xtandi Enzalutamide | 17 | 17 | Under 11 | $221K |
| Loperamide Loperamide Hcl | 16 | 16 | Under 11 | $174 |
| Lenvima Lenvatinib Mesylate | 15 | 15 | Under 11 | $358K |
| Triamcinolone Acetonide Generic | 14 | 14 | Under 11 | $63.38 |
| Gabapentin Generic | 12 | 12 | Under 11 | $64.92 |
Brand drugs: 305 claims; generic drugs: 277 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sumanta K Pal $1,010 ($1,010 in general payments such as food, travel and fees) from 8 companies. The largest payer was Exelixis Inc. with $599.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.